Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.24.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
Research and development $ 4,069,766 $ 5,651,041
General and administrative 3,972,140 4,023,445
Total operating expenses 8,041,906 9,674,486
Loss from operations (8,041,906) (9,674,486)
Other income and expenses:    
Interest income, net (247,216) (63,573)
Net loss $ (7,794,690) $ (9,610,913)
Net loss per share of common stock, basic and diluted $ (2.67) $ (13.92)
Weighted-average basic and diluted common shares 2,924,398 690,666